A retrospective chart review study to determine the effects of psychotropic medicationsand prior psychiatric diagnoses on COVID-19 patients' disease progression, and severity.
The goal of this study would be to study the association between use of psychotropic
medications and prior psychiatric diagnoses on COVID-19 patients' disease progression and
severity.
Other: No intervention
Observational study
Inclusion Criteria:
- Individuals with a positive COVID-19 test between March 15 2020 to November 30 2021
at Northwestern Medicine hospitals.
Exclusion Criteria:
-
Northwester Clinical Research Program
Chicago, Illinois, United States
Jeffrey Rado, MD, Principal Investigator
Northwestern University